Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Will Fed‘s Cap On Interest Rates Trigger Gold’s Rally?

Last week, the FOMC released the minutes from its last meeting. What implications do they carry for the gold market? FOMC Finally Acknowledges the Situation As Serious Last week, the FOMC has published minutes of its meeting from April 28-29. They show that the Fed...
Arkadiusz Sieron | May 27, 2020 |

Fed Stays Steady While BoJ Expands the Stimulus. What About Gold?

This week is hot for central banking: the Bank of Japan and the Federal Reserve have already held their monetary policy meetings. The former expanded its monetary policy easing, while the Fed remained steady. What do all these actions imply for the gold market? Bank of...
Arkadiusz Sieron | May 1, 2020 |

A psychedelic renaissance

Fifty-three years after LSD was banned by the FDA, psychedelic drugs are making a comeback. Only instead of being the pills, mushrooms and acid tabs that helped college students to “turn on, tune in, drop out” Timothy Leary-style, today’...
Richard (Rick) Mills | December 3, 2019 |

East-West Trade War: Never Take a Knife to a Gunfight

It's a funny thing that happens when the stress of financial insolvency bubbles up to the surface. Decisions once considered "routine" (like brushing one's teeth or walking one's dog) suddenly have life-or-death outcomes, complete with cold sweats, sleepless nights and ...
Streetwise Reports | October 11, 2019 |

The Repo Liquidity Crunch Reveals Market Stress. Will Gold Shine?

Last week, the Fed had to inject liquidity into the repo market for the first time since the Great Recession . Not once, but several times – and also commit to do more. Will such a crack in the proverbial dam let gold’s allure shine? Scramble for Liquidity ...
Arkadiusz Sieron | September 24, 2019 |

June 18th 2020, Silver Chartbook – Make it your own

Make it your own Trading is often compared to professional sports. This not only due to the competitive element. To produce outstanding performance different methodologies are required to reach elevated performance levels. Successful market participation is not achiev...
Korbinian Koller | June 19, 2020 |

Steady Gold Amid Choppy Recovery

Initial jobless claims are declining painfully slowly. The disconnect between the choppy recovery and financial markets creates upward risk for gold. The initial jobless claims still paint grim picture . They amounted to 1.48 million in the week from June 13 to June 2...
Arkadiusz Sieron | July 2, 2020 |

The New Cannabis & CBD Therapy for PTSD

This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...
Stockhouse Media | November 6, 2019 |

Ardelyx's Shares Soar 65% as Tenapanor Phase 3 Study Hits the Mark

Clinical-stage specialized biopharmaceutical company Ardelyx announced positive results today for its phase 3 AMPLIFY study for tenapanor aimed at improving treatment for cardiorenal diseases. This morning clinical-stage biopharmaceutical developer of medicines for th...
Streetwise Reports | September 4, 2019 |

All That Glitters When the World Jitters is Probably Gold

The economic pressures and concerns within the global markets have not abated just because the US Fed has ramped up the printing presses. Inversely, the stock market price levels may be elevated based on a false expectation of a quick recovery and of future expectations that...
Chris Vermeulen | June 22, 2020 |
1 2 3 4 5 6 7 8 9 10 ...